Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Healthy Volunteers Diabetes Mellitus, Type 2”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01919684
What this trial is testing

Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LGD-6972 in Healthy Subjects and Subjects With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus
Ligand Pharmaceuticals 56
Early research (Phase 1)Study completedNCT06141590
What this trial is testing

A Clinical Study to Evaluate the Safety and the Pharmacokinetics of UI068 in Healthy Adult Volunteers Under Fed Conditions

Who this might be right for
Diabetes Mellitus, Type 2
Korea United Pharm. Inc. 35
Testing effectiveness (Phase 2)Ended earlyNCT00633997
What this trial is testing

Assessment of the Skin-concentration of Vildagliptin 50 mg Every 12 Hours for 10 Days in Healthy Subjects and Patients With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Novartis 22
Early research (Phase 1)Study completedNCT01211197
What this trial is testing

Bioavailability of a Fixed Dose Combination Tablet With Empagliflozin (BI 10773) and Metformin Compared With the Monocomponents and Effect of Food on Bioavailability

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 16
Early research (Phase 1)Active Not RecruitingNCT07223333
What this trial is testing

PATAS Using Single Ascending Doses in Healthy Volunteers and Multiple Ascending Doses in Diabetic Subjects

Who this might be right for
Type 2 Diabetes
AdipoPharma LLC 56
Early research (Phase 1)Study completedNCT02942914
What this trial is testing

LY3209590 in Healthy Participants and Participants With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Eli Lilly and Company 80
Post-approval studies (Phase 4)Study completedNCT00885638
What this trial is testing

Effects of Dipeptidyl Peptidase-4 (DPP-4) Inhibition on Hormonal Responses to Macronutrient Ingestion

Who this might be right for
HealthyType 2 Diabetes
Lund University 12
Early research (Phase 1)Study completedNCT00605449
What this trial is testing

A Drug Interaction Study Between Simvastatin and GSK376501

Who this might be right for
Type 2 Diabetes Mellitus
GlaxoSmithKline 39
Early research (Phase 1)Study completedNCT00836225
What this trial is testing

Safety, Tolerability and Activity Study of Multiple Doses of ISIS-SGLT2Rx in Healthy Volunteers

Who this might be right for
Type 2 Diabetes Mellitus
Ionis Pharmaceuticals, Inc. 103
Early research (Phase 1)Study completedNCT01089192
What this trial is testing

Bioequivalence Study of Metformin Hydrochloride Extended Release 750 mg Tablets Versus Glucophage XR® 750 mg Tablet in Healthy Volunteers Under Fasting Conditions.

Who this might be right for
Type 2 Diabetes
Torrent Pharmaceuticals Limited
Early research (Phase 1)Study completedNCT01432938
What this trial is testing

The Effect of Dulaglutide on the Action of Warfarin in Healthy Participants

Who this might be right for
Diabetes Mellitus, Type 2
Eli Lilly and Company 28
Early research (Phase 1)Study completedNCT05579314
What this trial is testing

XW014 in Healthy Subjects and Patients With Type 2 Diabetes Mellitus (T2DM)

Who this might be right for
Type 2 Diabetes Mellitus
Sciwind Biosciences USA Co., Ltd. 127
Not applicableStudy completedNCT01900834
What this trial is testing

Evaluation of Biomarker Expression in Diabetic and Healthy Subjects Over a One Year Period

Who this might be right for
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2+1 more
Novo Nordisk A/S 61
Testing effectiveness (Phase 2)Study completedNCT05731544
What this trial is testing

Study of BMF-219 in Healthy Adult Subjects and in Adult Subjects With Type 2 Diabetes Mellitus (T2D)

Who this might be right for
Type 2 Diabetes Mellitus
Biomea Fusion Inc. 443
Early research (Phase 1)Study completedNCT05689099
What this trial is testing

A Research Trial Looking at the Comparability of 2 Different Concentrations of Semaglutide for the 0.5 Milligram (mg) Dose

Who this might be right for
Diabetes Mellitus, Type 2Healthy Participants
Novo Nordisk A/S 20
Early research (Phase 1)Study completedNCT06879132
What this trial is testing

Evaluate the Pharmacokinetics and Safety of BR3409 and Co-administration of BR3409-1 and BR3409-2 in Healthy Volunteers Under Fed Conditions

Who this might be right for
Type 2 Diabetes
Boryung Pharmaceutical Co., Ltd 40
Early research (Phase 1)Study completedNCT03169959
What this trial is testing

Evaluate the Food Effect on Drug Availability, Pharmacokinetic (PK) Properties, Safety and Tolerability of Two Different Dose Combination Therapy of Saxagliptin/Dapagliflozin/Metformin Extended-release (XR) Against Individual Component Co-administration.

Who this might be right for
Type 2 Diabetes Mellitus
AstraZeneca 85
Early research (Phase 1)Study completedNCT00519727
What this trial is testing

Safety Study of ISIS 325568 in Healthy Volunteers

Who this might be right for
Type 2 Diabetes Mellitus
Ionis Pharmaceuticals, Inc. 60
Early research (Phase 1)Ended earlyNCT01202266
What this trial is testing

A Multiple Dose Study Of PF-05161704 In Healthy Volunteers

Who this might be right for
Diabetes Mellitus, Type 2
Pfizer 32
Not applicableStudy completedNCT04387045
What this trial is testing

Perceived Stress and Negative Thoughts With Biomarkers in People With Type 2 Diabetes Mellitus and Healthy Subjects

Who this might be right for
Diabetes Mellitus, Type 2
Francisco Carlos López Marquez 40
Next Page